CANDESARTAN
Head Pain
Hospital Clínico Universitario de ValladolidSmall moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
14 Active assets in the Head Pain cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Topamax University of Minnesota | Phase 4 | BBB |
LIDOCAINE Daniel A Tonetti, MD | Phase 4 | BBB |
Treximet® Danish Headache Center | Phase 4 | BBB |
Prochlorperazine Wake Forest University Health Sciences | Phase 4 | BBB |
PROPOFOL Medical College of Wisconsin | Phase 4 | BBB |
View all 50 →
Same molecule, other indications
CANDESARTAN is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →